GeneDx Holdings Corp. (WGS)
WGS Stock Price Chart
Explore GeneDx Holdings Corp. interactive price chart. Choose custom timeframes to analyze WGS price movements and trends.
WGS Company Profile
Discover essential business fundamentals and corporate details for GeneDx Holdings Corp. (WGS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
4 Nov 2020
Employees
1.00k
Website
http://www.genedx.comCEO
Katherine A. Stueland
Description
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
WGS Financial Timeline
Browse a chronological timeline of GeneDx Holdings Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Aug 2026
EPS estimate is -$0.19, while revenue estimate is $111.01m.
Earnings released on 4 May 2026
EPS came in at -$0.28 falling short of the estimated -$0.06 by -366.67%, while revenue for the quarter reached $102.25m , missing expectations by -9.07%.
Earnings released on 23 Feb 2026
EPS came in at $0.14 surpassing the estimated $0.11 by +27.27%, while revenue for the quarter reached $121.00m , beating expectations by +0.56%.
Earnings released on 28 Oct 2025
EPS came in at $0.49 surpassing the estimated $0.28 by +75.00%, while revenue for the quarter reached $116.74m , missing expectations by -3.11%.
Earnings released on 29 Jul 2025
EPS came in at $0.50 surpassing the estimated $0.10 by +400.00%, while revenue for the quarter reached $102.69m , beating expectations by +4.11%.
Earnings released on 30 Apr 2025
EPS came in at $0.28 surpassing the estimated $0.11 by +154.55%, while revenue for the quarter reached $87.12m , beating expectations by +2.11%.
Earnings released on 18 Feb 2025
EPS came in at $0.70 surpassing the estimated $0.04 by +1.65k%, while revenue for the quarter reached $95.64m , beating expectations by +21.09%.
Earnings released on 29 Oct 2024
EPS came in at $0.04 surpassing the estimated -$0.19 by +121.05%, while revenue for the quarter reached $76.87m , missing expectations by -4.18%.
Earnings released on 30 Jul 2024
EPS came in at -$0.11 surpassing the estimated -$0.26 by +57.69%, while revenue for the quarter reached $70.51m , beating expectations by +18.89%.
Earnings released on 29 Apr 2024
EPS came in at -$0.33 surpassing the estimated -$0.68 by +51.47%, while revenue for the quarter reached $62.42m , beating expectations by +6.96%.
Earnings released on 20 Feb 2024
EPS came in at -$0.59 surpassing the estimated -$0.60 by +1.67%, while revenue for the quarter reached $57.42m , beating expectations by +3.59%.
Earnings released on 30 Oct 2023
EPS came in at -$0.82 surpassing the estimated -$1.18 by +30.51%, while revenue for the quarter reached $53.30m , beating expectations by +7.03%.
Earnings released on 8 Aug 2023
EPS came in at -$1.65 falling short of the estimated -$1.47 by -12.24%, while revenue for the quarter reached $48.71m , missing expectations by -9.77%.
Earnings released on 9 May 2023
EPS came in at -$2.82 falling short of the estimated -$1.65 by -70.91%, while revenue for the quarter reached $43.14m , missing expectations by -7.11%.
Stock split effective on 4 May 2023
Shares were split 1 : 33 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Mar 2023
EPS came in at -$0.25 falling short of the estimated -$0.16 by -56.25%, while revenue for the quarter reached $61.35m , missing expectations by -13.53%.
Earnings released on 14 Nov 2022
EPS came in at -$0.20 surpassing the estimated -$0.21 by +4.76%, while revenue for the quarter reached $83.23m , beating expectations by +22.87%.
Earnings released on 15 Aug 2022
EPS came in at -$0.25 falling short of the estimated -$0.21 by -19.05%, while revenue for the quarter reached $36.17m , missing expectations by -46.46%.
Earnings released on 12 May 2022
EPS came in at -$0.31 matching the estimated -$0.31, while revenue for the quarter reached $53.94m , beating expectations by +13.56%.
Earnings released on 14 Mar 2022
EPS came in at -$0.17 surpassing the estimated -$0.26 by +34.62%, while revenue for the quarter reached $57.80m , beating expectations by +16.37%.
Earnings released on 15 Nov 2021
EPS came in at -$0.43 falling short of the estimated -$0.19 by -126.32%, while revenue for the quarter reached $43.18m .
Earnings released on 21 Jul 2021
EPS came in at -$27.05 , while revenue for the quarter reached $47.02m .
WGS Stock Performance
Access detailed WGS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
